SCHEMBL23356897

SCHEMBL23356897

CNC(=O)c1ccc(CC(CN)N(C)C)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 2/20 0.48
▸ HDAC8 Q9BY41 2/20 0.47
▸ OPRM1 P35372 4/20 0.45
▸ HSP90AA1 P07900 1/20 0.40
▸ OPRD1 P41143 2/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ EPHX2 P34913 2/20 0.38
▸ NR1H4 Q96RI1 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ IP6K1 Q92551 1/20 0.38
▸ PLK1 P53350 1/20 0.38
▸ SLC7A5 Q01650 1/20 0.38
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ PLAU P00749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23356896 1.00 OPRK1 (0.48) OPRK1HDAC8OPRM1HSP90AA1OPRD1
SCHEMBL30980891 0.90 SLC6A2 (0.41) OPRK1HDAC8OPRM1HSP90AA1OPRD1
SCHEMBL23357301 0.90 SLC6A2 (0.41) OPRK1HDAC8OPRM1HSP90AA1OPRD1
SCHEMBL23357300 0.90 SLC6A2 (0.41) OPRK1HDAC8OPRM1HSP90AA1OPRD1
SCHEMBL25152119 0.86 OPRD1 (0.50) OPRK1HDAC8OPRM1OPRD1SLC6A2
SCHEMBL21439562 0.85 OPRK1 (0.59) OPRK1OPRM1SLC6A2SLC6A4SLC6A3
SCHEMBL21439561 0.85 OPRK1 (0.59) OPRK1OPRM1SLC6A2SLC6A4SLC6A3
SCHEMBL25152877 0.85 OPRD1 (0.43) HDAC8OPRM1OPRD1SLC6A2SLC6A4
SCHEMBL21447218 0.79 OPRK1 (0.52) OPRK1HDAC8OPRM1OPRD1HPGD
SCHEMBL21447544 0.79 OPRK1 (0.52) OPRK1HDAC8OPRM1OPRD1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774722-B1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE INC (US) 2024-07-24 — — EP disclosed
US-20240092746-A1 OPIOID RECEPTOR MODULATORS EPIODYNE, INC. 2024-03-21 — — US disclosed
US-11634396-B2 Opioid receptor modulators EPIODYNE, INC. (US) 2023-04-25 — — US disclosed
US-11352316-B2 Opioid receptor modulators and products and methods related thereto EPIODYNE, INC. (US) 2022-06-07 — — US disclosed
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-06-03 — — US disclosed
CN-112867705-A Opioid receptor modulators and products and methods related thereto 埃皮欧黛公司 2021-05-28 — — CN disclosed
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092746-A1 OPIOID RECEPTOR MODULATORS OPRM1, OPRK1, OPRL1 OPRK1 2/4885HDAC8 1258/4885OPRM1 1/4885
US-11352316-B2 Opioid receptor modulators and products and methods related thereto OPRM1, OPRD1, OPRK1 OPRK1 3/4885HDAC8 2278/4885OPRM1 1/4885
US-11634396-B2 Opioid receptor modulators OPRM1, OPRK1, OPRL1 OPRK1 2/4885HDAC8 1258/4885OPRM1 1/4885
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRK1 3/4885HDAC8 2278/4885OPRM1 1/4885
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRK1 3/4885HDAC8 2039/4885OPRM1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback